The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 32, Issue 10, 2019, Pages 1703-1720

  Pacora, Percy ^a,b   Romero, Roberto ^a,b,c,d   Erez, Offer ^a,b   Maymon, Eli ^a,b   Panaitescu, Bogdan ^a,b   Kusanovic, Juan Pedro ^e,f   Tarca, Adi L ^a,b   Hsu, Chaur Dong ^b   Hassan, Sonia S ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Amniotic fluid; Candida albicans; fetus; newborn; pregnancy

Indexed keywords

BETA GLUCAN; INTERLEUKIN 6;

ADULT; AEROBIC BACTERIUM; AMNION FLUID ANALYSIS; AMNIONITIS; ANAEROBIC BACTERIUM; ARTICLE; CANDIDA; CANDIDIASIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; HUMAN; LIMULUS LYSATE TEST; MAJOR CLINICAL STUDY; MYCOPLASMA; NONHUMAN; POINT OF CARE TESTING; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPECIES INVASION; ADVERSE DEVICE EFFECT; AMNIOCENTESIS; AMNION FLUID; CASE CONTROL STUDY; FETUS ECHOGRAPHY; GESTATIONAL AGE; INTRAUTERINE CONTRACEPTIVE DEVICE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREDICTIVE VALUE; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; BETA-GLUCANS; CANDIDA; CANDIDIASIS; CASE-CONTROL STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INTRAUTERINE DEVICES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 85039171197     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2017.1416083     Document Type: Article

References (241)

1. Whyte RK, Hussain Z, deSa D., Antenatal infections with Candida species. Arch Dis Child. 1982;57:528–535.
2. Romero R, Reece EA, Duff GW, et al. Prenatal diagnosis of Candida albicans chorioamnionitis. Am J Perinatol. 1985;2:121–122.
3. Bruner JP, Elliott JP, Kilbride HW, et al. Candida chorioamnionitis diagnosed by amniocentesis with subsequent fetal infection. Am J Perinatol. 1986;3:213–218.
4. Donders GG, Moerman P, Caudron J, et al. Intra-uterine Candida infection: a report of four infected fetusses from two mothers. Eur J Obstet Gynecol Reprod Biol. 1991;38:233–238.
5. Roqué H, Abdelhak Y, Young BK., Intra amniotic candidiasis. Case report and meta-analysis of 54 cases. J Perinat Med. 1999;27:253–262.
6. Bittencourt AL, dos Santos WL, de Oliveira CH., Placental and fetal candidiasis. Presentation of a case of an abortus. Mycopathologia. 1984;87:181–187.
7. Nichols A, Khong TY, Crowther CA., Candida tropicalis chorioamnionitis. Am J Obstet Gynecol. 1995;172:1045–1047.
8. Marelli G, Mariani A, Frigerio L, et al. Fetal Candida infection associated with an intrauterine contraceptive device. Eur J Obstet Gynecol Reprod Biol. 1996;68:209–212.
9. Asemota OA, Nyirjesy P, Fox R, et al. Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy. Fertil Steril. 2011;95:803.e1–803.e2.
10. Özer E, Ünlü M, Erşen A, et al. Intrauterine fetal loss associated with Candida glabrata chorioamnionitis: report of two cases. Turk Patoloji Derg. 2013;29:77–79.
11. Jackel D, Lai K., Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilization pregnancy: case report and review. Clinical Infectious Diseases. 2013;56:555–558.
12. Benirschke K, Raphael SI., Candida albicans infection of the amniotic sac. Am J Obstet Gynecol. 1958;75:200–202.
13. Lopez E, Aterman K., Intra-uterine infection by Candida American. Am J Dis Child. 1968;115:663–670.
14. Baley JE., Neonatal candidiasis: the current challenge. Clin Perinatol. 1991;18:263–280.
15. Baley JE, Annable WL, Kliegman RM., Candida endophthalmitis in the premature infant. J Pediatr. 1981;98:458–461.
16. Baley JE, Kliegman RM, Boxerbaum B, et al. Fungal colonization in the very low birth weight infant. Pediatrics. 1986;78:225–232.
17. Baley JE, Kliegman RM, Fanaroff AA., Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics. 1984;73:144–152.
18. Baley JE, Silverman RA., Systemic candidiasis: cutaneous manifestations in low birth weight infants. Pediatrics. 1988;82:211–215.
19. Aruna C, Seetharam K., Congenital candidiasis. Indian Dermatol Online J. 2014;5(Suppl1):S44–S47.
20. Garcia-Flores J, Cruceyra M, Cañamares M, et al. Candida chorioamnionitis: report of two cases and review of literature. J Obstet Gynaecol. 2016;36:843–844.
21. Chaim W, Mazor M, Wiznitzer A., The prevalence and clinical significance of intraamniotic infection with Candida species in women with preterm labor. Arch Gynecol Obstet. 1992;251:9–15.
22. Romero R, Sirtori M, Oyarzun E, et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 1989;161:817–824.
23. Romero R, Emamian M, Quintero R, et al. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol. 1988;159:114–119.
24. Romero R, Quintero R, Oyarzun E, et al. Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol. 1988;159:661–666.
25. Romero R, Mazor M, Wu YK, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol. 1988;12:262–279.
26. Romero R, Mazor M., Infection and preterm labor. Clin Obstet Gynecol. 1988;31:553–584.
27. Kellogg SG, Davis C, Benirschke K., Candida parapsilosis: previously unknown cause of fetal infection. A report of two cases. J Reprod Med. 1974;12:159–162.
28. Romero R, Nores J, Hagay Z, et al. Intraamniotic infection with Candida tropicalis in preterm labor. J Matern Fetal Neonatal Med. 1992;1:231–233.
29. Barth T, Broscheit J, Bussen S, et al. Maternal sepsis and intrauterine fetal death resulting from Candida tropicalis chorioamnionitis in a woman with a retained intrauterine contraceptive device. Acta obstet gynecol Scand. 2002;81:981–982.
30. Canpolat FE, Çekmez F, Tezer H., Chorioamnionitis and neonatal sepsis due to Candida tropicalis. Arch Gynecol Obstet. 2011;283:919–920.
31. Alfei A, Rizzo A, Cavanna C, et al. Candida glabrata and pre-term premature rupture of membrane complicating in vitro pregnancy: case report and confirmation of mother to neonate transmission. Arch Gynecol Obstet. 2014;290:211–214.
32. Ganer Herman H, Mevorach Zussman N, Krajden Haratz K, et al. Candida glabrata chorioamnionitis following in vitro fertilization: review of the Literature. Gynecol Obstet Invest. 2015;80:145–147.
33. Bobitt JR, Hayslip CC, Damato JD., Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor. Am J Obstet Gynecol. 1981;140:947–952.
34. Wallace RL, Herrick CN., Amniocentesis in the evaluation of premature labor. Obstet Gynecol. 1981;57:483–486.
35. Hameed C, Tejani N, Verma UL, et al. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy. Am J Obstet Gynecol. 1984;149:726–730.
36. Wahbeh CJ, Hill GB, Eden RD, et al. Intra-amniotic bacterial colonization in premature labor. Am J Obstet Gynecol. 1984;148:739–743.
37. Iams JD, Clapp DH, Contos DA, et al. Does extra-amniotic infection cause preterm labor? Gas–liquid chromatography studies of amniotic fluid in amnionitis, preterm labor, and normal controls. Obstet Gynecol. 1987;70:365–368.
38. Duff P, Kopelman JN., Subclinical intra-amniotic infection in asymptomatic patients with refractory preterm labor. Obstet Gynecol. 1987;69:756–759.
39. Skoll MA, Moretti ML, Sibai BM., The incidence of positive amniotic fluid cultures in patients preterm labor with intact membranes. Am J Obstet Gynecol. 1989;161:813–816.
40. Harger JH, Meyer MP, Amortegui A, et al. Low incidence of positive amnionic fluid cultures in preterm labor at 27–32 weeks in the absence of clinical evidence of chorioamnionitis. Obstet Gynecol. 1991;77:228–234.
41. Garite TJ, Freeman RK, Linzey EM, et al. The use of amniocentesis in patients with premature rupture of membranes. Obstet Gynecol. 1979;54:226–230.
42. Garite TJ, Freeman RK., Chorioamnionitis in the preterm gestation. Obstet Gynecol. 1982;59:539–545.
43. Cotton DB, Hill LM, Strassner HT, et al. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol. 1984;63:38–43.
44. Broekhuizen FF, Gilman M, Hamilton PR., Amniocentesis for Gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol. 1985;66:316–321.
45. Vintzileos AM, Campbell WA, Nochimson DJ, et al. Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm premature rupture of the membranes. Obstet Gynecol. 1986;67:579–583.
46. Feinstein SJ, Vintzileos AM, Lodeiro JG, et al. Amniocentesis with premature rupture of membranes. Obstet Gynecol. 1986;68:147–152.
47. Mazor M, Chaim W, Shinwell ES, et al. Asymptomatic amniotic fluid invasion with Candida albicans in preterm premature rupture of membranes. Implications for obstetric and neonatal management. Acta obstet gynecol Scand. 1993;72:52–54.
48. Shalev E, Battino S, Romano S, et al. Intraamniotic infection with Candida albicans successfully treated with transcervical amnioinfusion of amphotericin. Am J Obstet Gynecol. 1994;170:1271–1272.
49. Bean LM, Jackson JR, Dobak WJ, et al. Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection. Obstet Gynecol. 2013;121:452–454.
50. Murray PR, Masur H., Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit Care Med. 2012;40:3277–3282.
51. Bosshard PP., Incubation of fungal cultures: how long is long enough? Mycoses. 2011;54:e539–e545.
52. Obayashi T, Yoshida M, Mori T, et al. Plasma (1–>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 1995;345:17–20.
53. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39:199–205.
54. Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1–>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654–659.
55. Yasuoka A, Tachikawa N, Shimada K, et al. (1–>3) Beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab Immunol. 1996;3:197–199.
56. Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol. 2012;50:7–15.
57. Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1 –> 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol. 1997;35:371–374.
58. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. Beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clinical Infectious Diseases. 2011;52:750–770.
59. Raggam RB, Fischbach LM, Prattes J, et al. Detection of (1→3)-beta-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies. Mycoses. 2015;58:394–398.
60. Malani AN, Singal B, Wheat LJ, et al. (1,3)-Beta-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections. J Clin Microbiol. 2015;53:799–803.
61. Salvatore CM, Chen TK, Toussi SS, et al. (1→3)-Beta-d-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus Infections of the central nervous system in Pediatric Patients. J Pediatr Infect Dis Soc. 2016;5:277–286.
62. Stevens DA, Zhang Y, Finkelman MA, et al. Cerebrospinal fluid (1,3)-beta-d-glucan testing is useful in diagnosis of coccidioidal meningitis. J Clin Microbiol. 2016;54:2707–2710.
63. Litvintseva AP, Lindsley MD, Gade L, et al. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis. 2014;58:622–630.
64. Lyons JL, Thakur KT, Lee R, et al. Utility of measuring (1,3)-beta-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection. J Clin Microbiol. 2015;53:319–322.
65. Worasilchai N, Leelahavanichkul A, Kanjanabuch T, et al. (1→3)-Beta-D-glucan and galactomannan testing for the diagnosis of fungal peritonitis in peritoneal dialysis patients, a pilot study. Med Mycol. 2015;53:338–346.
66. Ginocchio F, Verrina E, Furfaro E, et al. Case Report of the Reliability 1,3-beta-D-glucan Monitoring during Treatment of peritoneal Candidiasis in a Child Receiving Continuous peritoneal dialysis. Clin Vaccine Immunol. 2012;19:626–627.
67. Rizzo G, Capponi A, Vlachopoulou A, et al. The diagnostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor and intact membranes. J Perinat Med. 1997;25:461–468.
68. Lam-Rachlin J, Romero R, Korzeniewski SJ, et al. Infection and smoking are associated with decreased plasma concentration of the anti-aging protein, alpha-klotho. J Perinat Med. 2013;41:581–594.
69. Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes. J Matern Fetal Neonatal Med. 2016;29:349–359.
70. Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection. J Matern Fetal Neonatal Med. 2016;29:360–367.
71. Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med. 2001;29:308–316.
72. Park KH, Chaiworapongsa T, Kim YM, et al. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med. 2003;31:12–22.
73. Berger A, Witt A, Haiden N, et al. Microbial invasion of the amniotic cavity at birth is associated with adverse short-term outcome of preterm infants. J Perinat Med. 2003;31:115–121.
74. Romero R, Miranda J, Chaiworapongsa T, et al. A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol. 2014;71:330–358.
75. Romero R, Miranda J, Kusanovic JP, et al. Clinical chorioamnionitis at term I: Microbiology of the amniotic cavity using cultivation and molecular techniques. J Perinat Med. 2015;43:19–36.
76. Romero R, Chaemsaithong P, Korzeniewski SJ, et al. Clinical chorioamnionitis at term II: the intra-amniotic inflammatory response. J Perinat Med. 2016;44:5–22.
77. Romero R, Chaemsaithong P, Korzeniewski SJ, et al. Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection? J Perinat Med. 2016;44:23–32.
78. Romero R, Chaemsaithong P, Docheva N, et al. Clinical chorioamnionitis at term IV: The maternal plasma cytokine profile. J Perinat Med. 2016;44:77–98.
79. Romero R, Chaemsaithong P, Docheva N, et al. Clinical chorioamnionitis at term VI: Acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity. J Perinat Med. 2016;44:33–51.
80. Martinez-Varea A, Romero R, Xu Y, et al. Clinical chorioamnionitis at term VII: The amniotic fluid cellular immune response. J Perinat Med. 2017;45:523–538.
81. Chaiyasit N, Romero R, Chaemsaithong P, et al. Clinical chorioamnionitis at term VIII: A rapid MMP-8 test for the identification of intra-amniotic inflammation. J Perinat Med. 2017;45:539–550.
82. Yoon BH, Romero R, Moon JB, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2001;185:1130–1136.
83. Kim KW, Romero R, Park HS, et al. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol. 2007;197:292.e1–292.e5.
84. Park CW, Lee SM, Park JS, et al. The antenatal identification of funisitis with a rapid MMP-8 bedside test. J Perinat Med. 2008;36:497–502.
85. Pacora P, Romero R, Chaiworapongsa T, et al. Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation. J Perinat Med. 2009;37:503–511.
86. Madan I, Romero R, Kusanovic JP, et al. The frequency and clinical significance of intra-amniotic infection and/or inflammation in women with placenta previa and vaginal bleeding: an unexpected observation. J Perinat Med. 2010;38:275–279.
87. Romero R, Chaiworapongsa T, Alpay Savasan Z, et al. Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med. 2011;24:1444–1455.
88. Park KH, Kim SN, Oh KJ, et al. Noninvasive prediction of intra-amniotic infection and/or inflammation in preterm premature rupture of membranes. Reprod Sci. 2012;19:658–665.
89. Romero R, Miranda J, Chaiworapongsa T, et al. Sterile intra-amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J Matern Fetal Neonatal Med. 2015;28:1343–1359.
90. Romero R, Miranda J, Chaemsaithong P, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2015;28:1394–1409.
91. Romero R, Chaemsaithong P, Chaiyasit N, et al. CXCL10 and IL-6: markers of two different forms of intra-amniotic inflammation in preterm labor. Am J Reprod Immunol. 2017;78.
92. Romero R, Miranda J, Chaiworapongsa T, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014;72:458–474.
93. Kedzierska A, Kochan P, Pietrzyk A, et al. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1–>3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis. 2007;26:755–766.
94. Tamura H, Arimoto Y, Tanaka S, et al. Automated kinetic assay for endotoxin and (1–>3)-beta-D-glucan in human blood. Clin Chim Acta. 1994;226:109–112.
95. Aketagawa J, Tanaka S, Tamura H, et al. Activation of limulus coagulation factor G by several (1–>3)-beta-D-glucans: comparison of the potency of glucans with identical degree of polymerization but different conformations. J Biochem. 1993;113:683–686.
96. Sobel JD., Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214:15–21.
97. Aguin TJ, Sobel JD., Vulvovaginal candidiasis in pregnancy. Curr Infect Dis Rep. 2015;17:462.
98. Ilkit M, Guzel AB., The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective. Crit Rev Microbiol. 2011;37:250–261.
99. Farr A, Kiss H, Holzer I, et al. Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome. Acta obstet gynecol Scand. 2015;94:989–996.
100. Holzer I, Farr A, Kiss H, et al. The colonization with Candida species is more harmful in the second trimester of pregnancy. Arch Gynecol Obstet. 2017;295:891–895.
101. Roberts CL, Rickard K, Kotsiou G, et al. Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. BMC Pregnancy Childbirth. 2011;11:18.
102. Friebe-Hoffmann U, Bender DP, Sims CJ, et al. Candida albicans chorioamnionitis associated with preterm labor and sudden intrauterine demise of one twin. A case report. J Reprod Med. 2000;45:354–356.
103. Kim SK, Romero R, Kusanovic JP, et al. The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med. 2010;38:45–53.
104. Smith CV, Horenstein J, Platt LD., Intraamniotic infection with Candida albicans associated with a retained intrauterine contraceptive device: a case report. Am J Obstet Gynecol. 1988;159:123–124.
105. Spaun E, Klünder K., Candida chorioamnionitis and intra-uterine contraceptive device. Acta obstet gynecol Scand. 1986;65:183–184.
106. Kusanovic JP, Romero R, Martinovic C, et al. Transabdominal collection of amniotic fluid “sludge” and identification of Candida albicans intra-amniotic infection. J Matern Fetal Neonatal Med. 2017 [May 3];[6 p.]. DOI:10.1080/14767058.2017.1315095
107. Sundaram A, Vaughan B, Kost K, et al. Contraceptive failure in the United States: estimates from the 2006–2010 national survey of family growth. Perspect Sex Reprod Health. 2017;49:7–16.
108. Teal SB, Romer SE, Goldthwaite LM, et al. Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol. 2015;213:515.e1–515.e5.
109. American College, Long-Acting Reversible Contraception Working Group. ACOG Committee Opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2009;114:1434–1438.
110. Gynecologists ACoOa. Committee opinion No. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120:983–988.
111. Diedrich JT, Madden T, Zhao Q, et al. Long-term utilization and continuation of intrauterine devices. Am J Obstet Gynecol. 2015;213:822.e1–822.e6.
112. Michaud P, Lemaire B, Tescher M., Spontaneous abortion with an IUD and Candida chorioamnionitis. Avortement spontane d’une grossesse sur DIU par chorioamniotite a Candida. Rev Fr Gynecol Obstet. 1989;84:45–46.
113. Brahmi D, Steenland MW, Renner RM, et al. Pregnancy outcomes with an IUD in situ: a systematic review. Contraception. 2012;85:131–139.
114. Chaim W, Mazor M, Meril T, et al. Late miscarriage and intraamniotic candidiasis in a woman with a retained intrauterine contraceptive device. Arch Gynecol Obstet. 1993;253:157–160.
115. Chaim W, Mazor M., Pregnancy with an intrauterine device in situ and preterm delivery. Arch Gynecol Obstet. 1992;252:21–24.
116. Dreishpoon IH., Complications of pregnancy with an intrauterine contraceptive device in situ. Am J Obstet Gynecol. 1975;121:412–413.
117. Ganer H, Levy A, Ohel I, et al. Pregnancy outcome in women with an intrauterine contraceptive device. Am J Obstet Gynecol. 2009;201:381.e1–381.e5.
118. Ozgu-Erdinc AS, Tasdemir UG, Uygur D, et al. Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis. Contraception. 2014;89:426–430.
119. Tatum HJ, Schmidt FH, Jain AK., Management and outcome of pregnancies associated with the copper T intrauterine contraceptive device. Am J Obstet Gynecol. 1976;126:869–879.
120. Waites KB, Bobo RA, Davis RO, et al. Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive device. Am J Obstet Gynecol. 1984;150:998–999.
121. Qureshi F, Jacques SM, Bendon RW, et al. Candida funisitis: a clinicopathologic study of 32 cases. Pediatr Dev Pathol. 1998;1:118–124.
122. Brandsma MA, Braaksma JT, van der Harten JJ., Immature delivery after intrauterine Candida albicans infection. Eur J Obstet Gynecol Reprod Biol. 1975;5:331–335.
123. Delprado WJ, Baird PJ, Russell P., Placental candidiasis: report of three cases with a review of the literature. Pathology. 1982;14:191–195.
124. Honoré LH., Placental candidiasis: report of two cases, one associated with an IUCD in situ. Contraception. 1984;30:555–560.
125. Ríos R, Aguilar R, Zaror L., Chorioamnionitis caused by candida associated with intrauterine devices. Corioamnionitis por Candida asociada a dispositivo intrauterino. Rev Chil Obstet Ginecol. 1988;53:297–298.
126. Bider D, Ben-Rafael Z, Barkai G, et al. Intrauterine fetal death apparently due to Candida chorioamnionitis. Arch Gynecol Obstet. 1989;244:175–177.
127. Mazor M, Chaim W, Pak I, et al. Intraamniotic infection with Candida albicans associated with a retained intrauterine device. A case report. J Reprod Med. 1992;37:950–952.
128. Horn LC, Nenoff P, Ziegert M, et al. Missed abortion complicated by Candida infection in a woman with rested IUD. Arch Gynecol Obstet. 2001;264:215–217.
129. Deveer R, Engin-Ustun Y, Sarikaya E, et al. Comparison of C-reactive protein levels in pregnancies with retained and removed intrauterine device. J Matern Fetal Neonatal Med. 2011;24:1152–1154.
130. Mermet J, Bolcato C, Rudigoz RC, et al. Outcome of pregnancies with an intrauterine devices and their management. Devenir des grossesses sur sterilet et conduite a tenir. Rev Fr Gynecol Obstet. 1986;81:233–235.
131. Potasman I, Leibovitz Z, Sharf M., Candida sepsis in pregnancy and the postpartum period. Rev Infect Dis. 1991;13:146–149.
132. Romero R, Lockwood CJ., Pathogenesis of spontaneous preterm labor. In: Creasy RK, Resnik R, Iams JD, editors. Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia, PA: Saunders; 2009. p. 521–543.
133. Gray DJ, Robinson HB, Malone J, et al. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn. 1992;12:111–117.
134. Gervasi MT, Romero R, Bracalente G, et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med. 2012;40:329–343.
135. Rowlands S, Danielewski JA, Tabrizi SN, et al. Microbial invasion of the amniotic cavity in midtrimester pregnancies using molecular microbiology. Am J Obstet Gynecol. 2017;217:71.e1–71.e5.
136. Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, et al. A critical assessment of the ‘sterile womb’ and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5:48.
137. Romero R, Nores J, Mazor M, et al. Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance. J Reprod Med. 1993;38:543–548.
138. Lee SE, Romero R, Kim CJ, et al. Funisitis in term pregnancy is associated with microbial invasion of the amniotic cavity and intra-amniotic inflammation. J Matern Fetal Neonatal Med. 2006;19:693–697.
139. McLean LK, Chehab FF, Goldberg JD., Detection of viral deoxyribonucleic acid in the amniotic fluid of low-risk pregnancies by polymerase chain reaction. Am J Obstet Gynecol. 1995;173:1282–1286.
140. Baschat AA, Towbin J, Bowles NE, et al. Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med. 2003;13:381–384.
141. Gervasi MT, Romero R, Bracalente G, et al. Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. J Matern Fetal Neonatal Med. 2012;25:2002–2013.
142. Espinoza J, Chaiworapongsa T, Romero R, et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med. 2003;13:2–21.
143. Miller J, Michel J, Bercovici B, et al. Studies on the antimicrobial activity of amniotic fluid. Am J Obstet Gynecol. 1976;125:212–214.
144. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119–1124.
145. Jarvis WR., The epidemiology of colonization. Infect Control Hosp Epidemiol. 1996;17:47–52.
146. Uko S, Soghier LM, Vega M, et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics. 2006;117:1243–1252.
147. Healy CM, Baker CJ, Zaccaria E, et al. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005;147:166–171.
148. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345:1660–1666.
149. Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 2007;356:2483–2495.
150. Appelbaum PC, Holloway Y, Ross SM, et al. The effect of amniotic fluid on bacterial growth in three population groups. Am J Obstet Gynecol. 1977;128:868–871.
151. Jankowski RP, Aikins HE, Vahrson H, et al. Antibacterial activity of amniotic fluid against Staphylococcus aureus, Candida albicans and Brucella abortus. Arch Gynecol. 1977;222:275–278.
152. Jackel D, Lai K., Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilization pregnancy: case report and review. Clin Infect Dis. 2013;56:555–558.
153. Johnsson H, Ewald U., The rate of candidaemia in preterm infants born at a gestational age of 23–28 weeks is inversely correlated to gestational age. Acta paediatr. 2004;93:954–958.
154. Poliquin V, Al-Sulmi E, Menticoglou S., Intra-amniotic infection involving Candida albicans subsequent to emergency cerclage: a case series. Can J Infect Dis Med Microbiol. 2015;26:245–246.
155. Sfameni SF, Talbot JM, Chow SL, et al. Candida glabrata chorioamnionitis following in vitro fertilization and embryo transfer. Aust N Z J Obstet Gynaecol. 1997;37:88–91.
156. Ibara AS, Marcorelles P, Le Martelot MT, et al. Two cases of systemic Candida glabrata infection following in vitro fertilization and embryo transfer. Eur J Clin Microbiol Infect Dis. 2004;23:53–56.
157. Akhanoba F, MacDougall J, Mathur R, et al. Severe systemic candidiasis following immunomodulation therapy in in vitro fertilisation-embryo transfer (IVF-ET). BMJ Case Rep. 2014 [Mar 31]. DOI:10.1136/bcr-2013-203202
158. Hayashi S, Mochizuki T, Watanabe S., Infection of human fetal membranes in vitro with Candida albicans. Mycoses. 1989;32:119–122.
159. Gürgan T, Diker KS, Haziroglu R, et al. In vitro infection of human fetal membranes with Candida species. Gynecol Obstet Invest. 1994;37:164–167.
160. Maudsley RF, Brix GA, Hinton NA, et al. Placental inflammation and infection. A prospective bacteriologic and histologic study. Am J Obstet Gynecol. 1966;95:648–659.
161. Kaufman D, Fairchild KD., Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev. 2004;17:638–80.
162. Engelhart CM, van de Vijver NM, Nienhuis SJ, et al. Fetal Candida sepsis at midgestation: a case report. Eur J Obstet Gynecol Reprod Biol. 1998;77:107–109.
163. Manzoni P, Farina D, Galletto P, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med. 2007;35:220–226.
164. Barton M, O’Brien K, Robinson JL, et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls. BMC Infect Dis. 2014;14:327.
165. Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics. 2006;117:e22–e32.
166. Payne MS, Kemp MW, Kallapur SG, et al. Intrauterine Candida albicans infection elicits severe inflammation in fetal sheep. Pediatr Res. 2014;75:716–722.
167. Stock SJ, Patey O, Thilaganathan B, et al. Intrauterine Candida albicans infection causes systemic fetal candidiasis with progressive cardiac dysfunction in a sheep model of early pregnancy. Reprod Sci. 2016 [May 23]. DOI:10.1177/1933719116649697
168. Di Naro E, Cromi A, Ghezzi F, et al. Myocardial dysfunction in fetuses exposed to intraamniotic infection: new insights from tissue Doppler and strain imaging. Am J Obstet Gynecol. 2010;203:459.e1–459.e7.
169. Ophelders DR, Gussenhoven R, Lammens M, et al. Neuroinflammation and structural injury of the fetal ovine brain following intra-amniotic Candida albicans exposure. J Neuroinflamm. 2016;13:29.
170. Nikiforou M, Jacobs EMR, Kemp MW, et al. Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine. Sci Rep. 2016;6:29806.
171. Berry DL, Olson GL, Wen TS, et al. Candida chorioamnionitis: a report of two cases. J Matern Fetal Med. 1997;6:151–154.
172. Maneenil G, Payne MS, Senthamarai Kannan P, et al. Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep. Pediatr Res. 2015;77:740–748.
173. Nien JK, Yoon BH, Espinoza J, et al. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol. 2006;195:1025–1030.
174. Chaemsaithong P, Romero R, Docheva N, et al. Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes. J Matern Fetal Neonatal Med. 2018;31:228–244.
175. Chaemsaithong P, Romero R, Korzeniewski SJ, et al. A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10. J Matern Fetal Neonatal Med. 2015;28:1510–1519.
176. Kacerovsky M, Musilova I, Stepan M, et al. Detection of intraamniotic inflammation in fresh and processed amniotic fluid samples with the interleukin-6 point of care test. Am J Obstet Gynecol. 2015;213:435–436.
177. Kacerovsky M, Musilova I, Hornychova H, et al. Bedside assessment of amniotic fluid interleukin-6 in preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2014;211:385.e1–385.e9.
178. Park CW, Yoon BH, Kim SM, et al. The frequency and clinical significance of intra-amniotic inflammation defined as an elevated amniotic fluid matrix metalloproteinase-8 in patients with preterm labor and low amniotic fluid white blood cell counts. Obstet Gynecol Sci. 2013;56:167–175.
179. Maymon E, Romero R, Chaiworapongsa T, et al. Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol. 2001;185:1149–1155.
180. Maymon E, Romero R, Chaiworapongsa T, et al. Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes. Am J Obstet Gynecol. 2001;185:1143–1148.
181. Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol. 2000;183:94–99.
182. Yoon BH, Oh SY, Romero R, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2001;185:1162–1167.
183. Park JS, Romero R, Yoon BH, et al. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol. 2001;185:1156–1161.
184. Angus SR, Segel SY, Hsu CD, et al. Amniotic fluid matrix metalloproteinase-8 indicates intra-amniotic infection. Am J Obstet Gynecol. 2001;185:1232–1238.
185. Moon JB, Kim JC, Yoon BH, et al. Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy. J Perinat Med. 2002;30:301–306.
186. Biggio JR, Jr., Ramsey PS, Cliver SP, et al. Midtrimester amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol. 2005;192:109–113.
187. Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014;210:125.e1–125.e15.
188. Kacerovsky M, Musilova I, Andrys C, et al. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am J Obstet Gynecol. 2014;210:325.e1–325.e10.
189. Cobo T, Palacio M, Navarro-Sastre A, et al. Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am J Obstet Gynecol. 2009;200:499.e1–499.e6.
190. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol. 2000;182:675–681.
191. Combs CA, Gravett M, Garite TJ., Reply: To PubMed: 24274987. Am J Obstet Gynecol. 2014;211:708–709.
192. Romero R, Avila C, Santhanam U, et al. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest. 1990;85:1392–1400.
193. Santhanam U, Avila C, Romero R, et al. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection. Cytokine. 1991;3:155–163.
194. Romero R, Sepulveda W, Kenney JS, et al. Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Found Symp. 1992;167:205–20; discussion 220. discussion:20–23.
195. Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 1993;169:805–816.
196. Romero R, Yoon BH, Mazor M, et al. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 1993;169:839–851.
197. Romero R, Yoon BH, Kenney JS, et al. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol. 1993;30:167–183.
198. Greig PC, Ernest JM, Teot L, et al. Amniotic fluid interleukin-6 levels correlate with histologic chorioamnionitis and amniotic fluid cultures in patients in premature labor with intact membranes. Am J Obstet Gynecol. 1993;169:1035–1044.
199. Gomez R, Romero R, Galasso M, et al. The value of amniotic-fluid interleukin-6, white blood-cell count, and Gram stain in the diagnosis of microbial invasion of the amniotic cavity in patients at term. Am J Reprod Immunol. 1994;32:200–210.
200. Coultrip LL, Lien JM, Gomez R, et al. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 1994;171:901–911.
201. Dudley DJ, Hunter C, Mitchell MD, et al. Clinical value of amniotic fluid interleukin-6 determinations in the management of preterm labour. Br J Obstet Gynaecol. 1994;101:592–597.
202. Yoon BH, Romero R, Kim CJ, et al. Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol. 1995;172:960–970.
203. Negishi H, Yamada H, Mikuni M, et al. Correlation between cytokine levels of amniotic fluid and histological chorioamnionitis in preterm delivery. J Perinat Med. 1996;24:633–639.
204. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1997;177:825–830.
205. Wenstrom KD, Andrews WW, Hauth JC, et al. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol. 1998;178:546–550.
206. Baud O, Emilie D, Pelletier E, et al. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol. 1999;106:72–77.
207. Yoon BH, Park CW, Chaiworapongsa T., Intrauterine infection and the development of cerebral palsy. BJOG. 2003;110:124–127.
208. Jacobsson B, Mattsby-Baltzer I, Andersch B, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta obstet gynecol Scand. 2003;82:423–431.
209. Jacobsson B, Mattsby-Baltzer I, Hagberg H., Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. BJOG. 2005;112:719–724.
210. Holst RM, Laurini R, Jacobsson B, et al. Expression of cytokines and chemokines in cervical and amniotic fluid: relationship to histological chorioamnionitis. J Matern Fetal Neonatal Med. 2007;20:885–893.
211. Menon R, Camargo MC, Thorsen P, et al. Amniotic fluid interleukin-6 increase is an indicator of spontaneous preterm birth in white but not black Americans. Am J Obstet Gynecol. 2008;198:77.e1–77.e7.
212. Massaro G, Scaravilli G, Simeone S, et al. Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience. J Matern Fetal Neonatal Med. 2009;22:1063–1067.
213. Thomakos N, Daskalakis G, Papapanagiotou A, et al. Amniotic fluid interleukin-6 and tumor necrosis factor-alpha at mid-trimester genetic amniocentesis: relationship to intra-amniotic microbial invasion and preterm delivery. Eur J Obstet Gynecol Reprod Biol. 2010;148:147–151.
214. Marconi C, de Andrade Ramos BRD, Peraçoli JC, et al. Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am J Reprod Immunol. 2011;65:549–556.
215. Cobo T, Kacerovsky M, Palacio M, et al. A prediction model of histological chorioamnionitis and funisitis in preterm prelabor rupture of membranes: analyses of multiple proteins in the amniotic fluid. J Matern Fetal Neonatal Med. 2012;25:1995–2001.
216. Cobo T, Kacerovsky M, Holst RM, et al. Intra-amniotic inflammation predicts microbial invasion of the amniotic cavity but not spontaneous preterm delivery in preterm prelabor membrane rupture. Acta obstet gynecol Scand. 2012;91:930–935.
217. Bogavac M, Brkic S, Simin N, et al. Mid-pregnancy interleukins levels in serum and amniotic fluid as predictors of preterm delivery. J Matern Fetal Neonatal Med. 2012 [Dec 4]. DOI:10.3109/14767058.2012.722709
218. Romero R, Kadar N, Miranda J, et al. The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6. J Matern Fetal Neonatal Med. 2014;27:757–769.
219. Cobo T, Jacobsson B, Kacerovsky M, et al. Systemic and local inflammatory response in women with preterm prelabor rupture of membranes. PLoS One. 2014;9:e85277.
220. ® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia. Med Mycol. 2017;55:843–850.
221. Lu Y, Chen YQ, Guo YL, et al. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis. Intern Med. 2011;50:2783–2791.
222. Mackay CA, Ballot DE, Perovic O., Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates. Pediatr Rep. 2011;3:e14.
223. Goudjil S, Kongolo G, Dusol L, et al. (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate. J Matern Fetal Neonatal Med. 2013;26:44–48.
224. Mularoni A, Furfaro E, Faraci M, et al. High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease. Clin Vaccine Immunol. 2010;17:882–883.
225. Montagna MT, Coretti C, Lovero G, et al. Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia. Int J Mol Sci. 2011;12:5871–5877.
226. Cornu M, Goudjil S, Kongolo G, et al. Evaluation of the (1,3)-beta-D-glucan assay for the diagnosis of neonatal invasive yeast infections. Med Mycol. 2018;56:78–87.
227. Romero R, Kadar N, Hobbins JC, et al. Infection and labor: the detection of endotoxin in amniotic fluid. Am J Obstet Gynecol. 1987;157:815–819.
228. Romero R, Kadar N, Lafreniere D, et al. Do blood and meconium affect the detection of endotoxin in amniotic fluid with the limulus amebocyte gel clot assay? Am J Perinatol. 1987;4:356–359.
229. Romero R, Roslansky P, Oyarzun E, et al. Labor and infection. II. Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet Gynecol. 1988;158:1044–1049.
230. Romero R, Yoon BH, Chaemsaithong P, et al. Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage? J Matern Fetal Neonatal Med. 2014;27:775–788.
231. Ramage G, Vandewalle K, Wickes BL, et al. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001;18:163–170.
232. Pál Z, Urbán E, Dósa E, et al. Biofilm formation on intrauterine devices in relation to duration of use. J Med Microbiol. 2005;54:1199–1203.
233. Zahran KM, Agban MN, Ahmed SH, et al. Patterns of Candida biofilm on intrauterine devices. J Med Microbiol. 2015;64:375–381.
234. Costerton JW, Stewart PS, Greenberg EP., Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–1322.
235. Marrie TJ, Costerton JW., A scanning and transmission electron microscopic study of the surfaces of intrauterine contraceptive devices. Am J Obstet Gynecol. 1983;146:384–394.
236. Jacques M, Marrie TJ, Costerton JW., Review. Microbial colonization of prosthetic devices. Microb Ecol. 1987;13:173–191.
237. Costerton JW, Cheng KJ, Geesey GG, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol. 1987;41:435–464.
238. Espinoza J, Gonçalves LF, Romero R, et al. The prevalence and clinical significance of amniotic fluid “sludge” in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol. 2005;25:346–352.
239. Kusanovic JP, Espinoza J, Romero R, et al. Clinical significance of the presence of amniotic fluid “sludge” in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2007;30:706–714.
240. Romero R, Kusanovic JP, Espinoza J, et al. What is amniotic fluid “sludge”? Ultrasound Obstet Gynecol. 2007;30:793–798.
241. Romero R, Schaudinn C, Kusanovic JP, et al. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol. 2008;198:135.e1–135.e5.